Latest Blogs

Aug 10, 2017
In a divisive time, I look to my patients and see that there is more that unites us than divides us, and this is worth celebrating.
Aug 04, 2017
Never doubt that your voice and time matter when it comes to trying to change the world in a positive way. We as a community can come together and really make a difference, and you can see it firsthand any weekend in almost any city across the country.
Aug 03, 2017
The line of thinking that women can do without their breasts only makes breast cancer treatment easier for us as physicians, not for our patients. When it's your own body, every organ is vital.
Aug 03, 2017
The program is now available for this year's Research Community Forum Annual Meeting. Dr. Richard L. Schilsky invites you to join this unique event on September 24-25 in Alexandria, VA.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Jun 29, 2017
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Jun 22, 2016
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
Jun 18, 2015
The AMA House of Delegates (AMA-HOD) convened a few days after the ASCO Annual Meeting.  It was, in many ways, a continuation of many of the concerns reviewed at the annual ASCO gathering. The delegation representing ASCO is now composed of ASCO staff, along with Drs. Thomas Marsland, Ray Page,...
Jun 01, 2015
The annual ASCO gathering is now in its last 48 hours, and it has been interesting. I have heard discussions concerning payment reform, oncology medical homes, and value based care. The highlighted plenary presentations concerning what appears to be a major clinical advance in the treatment of...

Pages